Fabry Highlights from the Worldsymposium Webinar with Dr Hopkin Feb 28Th at 6pm CET
Addressing the Challenges of Persons Living with a Rare Disease
We're are happy to share this great resource with you. This can support you in exploring different gene therapies approaches to treating Fabry disease! Have a look at the infographic to find out more!
Idorsia Ltd (SIX: IDIA) today announced that after the planned interim analysis of the open-label extension (OLE) of the Phase 3 MODIFY study with lucerastat for the treatment of adult patients with Fabry disease, the study will continue.